EP2506850

INTERMUNE
Application Number
EP10835207A
Filing Date
Dec 3, 2010
Status
Revoked
Feb 17, 2023
Grant Date
May 13, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2506850B1 was granted on May 13, 2020 by Intermune The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

INTAS PHARMACEUTICALSFeb 15, 2021WITHDRAWN
GENERICS UKFeb 12, 2021WITHDRAWN
SANDOZFeb 11, 2021WITHDRAWN
AERAFeb 3, 2021WITHDRAWN
ALFRED E TIEFENBACHERJan 26, 2021WITHDRAWN
STADA ARZNEIMITTELJan 26, 2021WITHDRAWN

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO9814169
N/A
OppositionUS7566729
N/A
OppositionEP2324831
N/A
OppositionEP2702994
N/A
OppositionEP3275196
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.